Aucta Drug Patent Portfolio
Aucta owns 1 orange book drug protected by 3 US patents Given below is the list of Aucta's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11337943 | Lacosamide pharmaceutical composition and dosage form thereof | 05 Jun, 2040 | Active |
| US11883374 | Lacosamide pharmaceutical composition and dosage form thereof | 05 Jun, 2040 | Active |
| US12042474 | Lacosamide pharmaceutical composition and dosage form thereof | 05 Jun, 2040 | Active |
Latest Legal Activities on Aucta's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Aucta.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Recordation of Patent Grant Mailed
Critical
| 24 May, 2022 | US11337943 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 24 May, 2022 | US11337943 |
|
Email Notification
Critical
| 05 May, 2022 | US11337943 |
|
Issue Notification Mailed
Critical
| 04 May, 2022 | US11337943 |
|
Application Is Considered Ready for Issue
Critical
| 26 Apr, 2022 | US11337943 |
| Dispatch to FDC | 26 Apr, 2022 | US11337943 |
|
Issue Fee Payment Verified
Critical
| 25 Apr, 2022 | US11337943 |
|
Issue Fee Payment Received
Critical
| 25 Apr, 2022 | US11337943 |
| Mail Post Card | 03 Feb, 2022 | US11337943 |
|
Email Notification
Critical
| 26 Jan, 2022 | US11337943 |
|
Mail Notice of Allowance
Critical
| 26 Jan, 2022 | US11337943 |
|
Notice of Allowance Data Verification Completed
Critical
| 24 Jan, 2022 | US11337943 |
| Date Forwarded to Examiner | 21 Dec, 2021 | US11337943 |
| PILOT- Request for After Final Consideration Program | 14 Dec, 2021 | US11337943 |
| Response after Final Action | 14 Dec, 2021 | US11337943 |
Aucta's Family Patents
Aucta Drug List
Given below is the complete list of Aucta's drugs and the patents protecting them.
1. Motpoly Xr
Motpoly Xr is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11337943 | Lacosamide pharmaceutical composition and dosage form thereof |
05 Jun, 2040
(15 years from now)
| Active |
| US11883374 | Lacosamide pharmaceutical composition and dosage form thereof |
05 Jun, 2040
(15 years from now)
| Active |
| US12042474 | Lacosamide pharmaceutical composition and dosage form thereof |
05 Jun, 2040
(15 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Motpoly Xr's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List